Pathology results in [f]fluorodeoxyglucose positron emission tomography of the thyroid gland

Nuclear Medicine Communications

Volumn 24, Issue 12, 2003, Pages 1225-1230

  Wolf, G ^a   Aigner, R M ^a   Schaffler, G ^a   Schwarz, T ^a   Krippl, P ^a  

^a Division of Nuclear Medicine   (Austria)

Author keywords

F FDG PET; Positron emission tomography; Thyroid; Thyroiditis; 99mTc pertechnetate scintigraphy

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID TUMOR; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 3142648032     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200312000-00004     Document Type: Article

References (16)

1. Bloom AD, Adler LP, Shuck JM. Determination of malignancy of thyroid nodules with positron emission tomography. Surgery 1993; 114: 728-734.
2. Sasaki M, Ichiya Y, Kuwabara Y, et al. An evaluation of FDG-PET in the detection and differentiation of thyroid tumours. Nucl Med Commun 1997; 18: 957-963.
3. Boerner AR, Voth E, Wienhard K, Wagner R, Schicha H. F-18-FDG-PET in autonomous goiter. Nuklearmedizin 1999; 38: 1-6.
4. Lind P, Kumnig G, Matschnig S, et al. The role of F-18-FDG-PET in thyroid cancer. Acta Med Austriaca 2000; 27: 38-41.
5. Jadvar H, McDougall IR, Segall GM. Evaluation of suspected recurrent papillary thyroid carcinoma with F-18-FDG-PET. Nucl Med Commun 1998; 19: 547-554.
6. 131I-negative papillary thyroid carcinoma. J Nucl Med 2000; 41: 1010-1015.
7. Muros MA, Llamas-Elvira JM, Ramirez-Navarro A, Gomez MJ, Rodriguez-Ferdinandez A, Muros T. Utility of F18-FDG-PET in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyreoglobulin levels. Am J Surg 2000; 179: 457-461.
8. Grunwald F, Kalicke T, Feine U, et al. F18-FDG-PET in thyroid cancer: results of a multicentre study. Eur J Nucl Med 1999; 26: 1547-1552.
9. 131I whole-body scan. J Nucl Med 1999; 40: 986-992.
10. Feine U. Fluorine-18-FDG and iodine-131-iodine uptake in thyroid cancer. J Nucl Med 1996; 37: 1468-1472.
11. McDougall R, Davidson J, Segall GM. Positron emission tomography of the thyroid, with an emphasis on thyroid cancer. Nucl Med Commun 2001; 22: 485-492.
12. Yasuda S, Shotsu A, Die M, et al. Chronic thyroiditis: diffuse uptake of FDG at PET. Radiology 1998; 207: 775-778.
13. Uematsu H, Sadato N, Ohtsubo T, et al. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors. J Nucl Med 1998; 39: 453-459.
14. Seiei Y, Akira S, Michiru I, Shigeharu T, Yasuhiro S, Tomoo T. Diffuse F18-FDG uptake in chronic thyroiditis. Clin Nucl Med 1996; 5: 341.
15. Passler C, Prager M, Scheuba C, et al. The value of fine-needle aspiration biopsy (FNAB) in the differential diagnosis of the ‘cold’ thyroid nodule. Wien Klin Wochenschr 1999; 111: 240-245.
16. Raber W, Kmen E, Kaserer K, Waldhausl W, Vierhapper H. The ‘cold’ nodule of the thyroid gland: 20 years experience with 2.071 patients and diagnostic limits of fine needle biopsy. Wien Klin Wochneschr 1997; 109: 116-122.